LGM
Logos Global Management’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,000,000
| Closed | -$4.8M | – | 48 |
|
|
2023
Q3 | $4.8M | Hold |
1,000,000
| – | – | 0.64% | 35 |
|
|
2023
Q2 | $7.51M | Sell |
1,000,000
-500,000
| -33% | -$3.76M | 1.02% | 30 |
|
|
2023
Q1 | $6.78M | Sell |
1,500,000
-849,600
| -36% | -$3.84M | 0.97% | 33 |
|
|
2022
Q4 | $26.5M | Sell |
2,349,600
-621,752
| -21% | -$7.01M | 3.1% | 14 |
|
|
2022
Q3 | $28.4M | Sell |
2,971,352
-165,000
| -5% | -$1.58M | 3.5% | 12 |
|
|
2022
Q2 | $25.4M | Buy |
3,136,352
+125,000
| +4% | +$1.01M | 4.66% | 10 |
|
|
2022
Q1 | $50.9M | Buy |
3,011,352
+105,000
| +4% | +$1.77M | 6.6% | 2 |
|
|
2021
Q4 | $62.5M | Sell |
2,906,352
-250,629
| -8% | -$5.39M | 6.44% | 1 |
|
|
2021
Q3 | $233M | Hold |
3,156,981
| – | – | 16.81% | 1 |
|
|
2021
Q2 | $173M | Hold |
3,156,981
| – | – | 14.51% | 1 |
|
|
2021
Q1 | $233M | Hold |
3,156,981
| – | – | 22.72% | 1 |
|
|
2020
Q4 | $272M | Buy |
3,156,981
+20,000
| +0.6% | +$1.72M | 23.33% | 1 |
|
|
2020
Q3 | $118M | Buy |
+3,136,981
| New | +$118M | 15.15% | 1 |
|